| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |